U.S. Regulation Of Abortion Pills Out Of Step With WHO Essential Medicines List, Advocates Say

Pacific Standard: An Update on Abortion Pills From the World Health Organization Undermines How the U.S. Regulates Them
“Abortion pills should be widely available and affordable, and don’t need to be dispensed by highly trained specialists or in specialty facilities, according to a World Health Organization update published last week. … The WHO has considered mifepristone and misoprostol ‘essential medicines’ since 2005, but in the recent update, WHO experts decided that they had enough scientific evidence to strike the caveat saying the medications require ‘close medical supervision.’ The change puts the United States’ strict regulations around abortion pills even further out of step with international guidelines, activists and scientists say. The WHO update isn’t legally binding, but many countries take the WHO essential medicines list seriously, so it may make mifepristone and misoprostol more readily available worldwide. In the U.S., however, not much is expected to change…” (Diep, 7/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.